The AVENGERS VS X-MEN crossover continued to dominate both franchises in July. There are also two new ongoing titles – CAPTAIN MARVEL and X-TREME X-MEN – which unusually launch in the middle of the big crossover. And while Marvel have generally eased off on their miniseries of late, we have two this month – SPACE PUNISHER and INFERNAL MAN-THING.

In terms of market share, DC won the month, leading Marvel by 37% to 35% in units and 33% to 32% in dollars. The other big news, of course, is the remarkable sales of WALKING DEAD #100, which topped the charts with an extraordinary estimated sale of over 335,000 – but that’s a story for another column. (It also seems like a good opportunity to remind people that these figures only reflect sales to the direct market in North America. Total sales are therefore bound to be higher once you factor in sales through other channels, most obviously to the UK and Europe.)

by Paul O’Brien

The AVENGERS VS X-MEN crossover continued to dominate Marvel’s schedule in June, but the month also saw another high profile release – the SPIDER-MEN miniseries, in which the original Spider-Man meets the new Ultimate Universe version of the character. The Icon imprint also launches a HIT-GIRL miniseries. And other than that, it’s a pretty quiet month for new releases, as often tends to be the case in the height of major crossovers.

Despite the sales boost from the summer crossover, it was a very close month in terms of market share in the North American direct market, with DC leading Marvel in unit terms by 38.2% to 37.8%, but Marvel leading in retail share by 33.8% to 33.0%. Effectively a tie, then. DC’s performance can be attributed in large part to all four BEFORE WATCHMEN titles landing in the top 10 with estimated sales of over 100K each.

The AVENGERS VS X-MEN crossover continued in May, while NEW MUTANTS and JOURNEY INTO MYSTERY had their own little private event with “Exiled”. There’s also the launch of the new FURY MAX title, the weekly mini HULK SMASH AVENGERS, more flogging of the undead horse with MARVEL ZOMBIES DESTROY!, and the return of Icon’s TAKIO.

As usual, Marvel had the largest share of the North American direct market, though by a smaller than usual margin – they led DC by 39% to 37% in unit share, and 35% to 33% in dollar terms.

The crossover season is now firmly underway, with the first proper month of AVENGERS VS X-MEN, and its assorted tie-ins, which are doing pretty well. There’s also the Omega Effect crossover between AVENGING SPIDER-MAN, DAREDEVIL and PUNISHER, all of which see big gains as a result. Further down the chart, Mark Millar launches another creator-owned book, SECRET SERVICE, through the Icon imprint; and the all-ages titles get another relaunch.

As you might expect, April was a good month for Marvel in terms of their market share. They led DC by 39% to 34% in units, and 35% to 30% in dollars.

Thanks as always to ICV2.com for permission to use these figures.

With Marvel refocussing on more issues of fewer titles, and with the next wave of new titles presumably not due until after AVENGERS VS X-MEN, it’s a pretty quiet month for new titles. The main new launch is WINTER SOLDIER, there’s the much-delayed return of THE TWELVE… and that’s pretty much it.

Normal service is resumed, as Marvel had the largest share of the direct market, leading DC by 39% to 35% in unit share, and 36% to 29% in dollars. Bear in mind, though, that February was a five week month and DC didn’t take advantage of that extra week to ship further material.

Thanks as always to ICV2.com for permission to use these figures.

By Paul O’Brien

Perhaps it’s a side effect of the decision to trim the line, but Marvel seem to have gone back to the days when each month had a small number of new launches that they could focus on properly. This month’s sole new title is SCARLET SPIDER, and the only major new miniseries is WOLVERINE AND THE X-MEN: ALPHA & OMEGA. There’s also WOLVERINE #300, and the second issue of the AvX lead-in mini AVENGERS: X-SANCTION.

DC’s resurgence continued in January, as once again Marvel faced a fight to be the top publisher in the direct market. In terms of market share, it’s really too close to call; DC led in units, by 40% to 38%, while Marvel led in dollars, by 36% to 34%. On the other hand, DC swept the top ten with the fifth issues of their regular titles – some of which are selling in a different league from anything in Marvel’s range. It’s been a long time since AQUAMAN was outselling the entire Marvel line.

Thanks as always to ICV2.com for permission to use these figures.

by Paul O’Brien

— This month, the slow build to AVENGERS VS X-MEN begins with the AVENGERS: X-SANCTION miniseries; and DEFENDERS is relaunched. Both are wisely given a pretty clear run, without other Marvel launches competing for space.

Elsewhere, the X-Men, Hulk and Fantastic Four relaunches continue to bed down. And down at the bottom end of the chart, the cancellations continue to mount up.

Normal service is resumed, kind of, as Marvel had the largest share of the north American direct market, albeit by a fairly narrow margin – 39% to 38% in units, 34.4% to 33.7% in dollars. But bear in mind, this was a five-week month where DC more or less sat out week five.

Welcome to month two of Bizarro World! This was quite a busy month for Marvel, with the “Fear Itself” crossover continuing, the relaunch of INCREDIBLE HULK, and the first issue of new title WOLVERINE & THE X-MEN.

But once again, the big story in October was the continued success of the DCU relaunch. DC’s lead over Marvel in September may have been narrow, but in October it was massive. Helped by hefty re-orders on virtually the entire September DCU line, DC led Marvel by 42% to 29% in dollars and a remarkable 51% to 30% in units. That market share is partly due to massive reorders on DC’s September line. It seems reasonable to assume that this won’t be a regular event, and that the gap won’t be quite so large in future. But the possibility that Marvel might have to readjust to life as the number two publisher cannot be ruled out.

Not that it’s doom and gloom by any means. DC’s sales are up, but not at Marvel’s expense. If the DC relaunch has brought new readers into stores, or old readers back, then in theory Marvel should be able to take advantage of that too. On the other hand, it also makes it rather harder for Marvel to argue that its books are losing sales because it’s a tough market. DC has just proved that declining sales are not inevitable.

Thanks as always to ICV2.com for permission to use these figures.

By Paul O’Brien — It’s the column you’ve been waiting for! The September sales – for Marvel!

Hello? Hello? Is this thing on?

Okay, so September was DC’s month. And understandably, most publishers got out of the way, rather than trying to launch any new titles against the New 52 onslaught. Marvel had the second month of the Ultimate relaunch, and there are a couple of new Icon books in the form of BRILLIANT and the returning CASANOVA, but that’s really about it where new launches are concerned. Of course, there’s also the continuing crossovers of “Fear Itself”, “Spider-Island” and “Schism”, and Marvel’s standard practice these days would be to launch the new books after those events, not during.

For the first time in quite a while, DC had the biggest share of the market, leading Marvel by 43% to 38% in units, and a razor-thin 36% to 35% in dollars. (Incidentally, those market share figures apparently don’t apply the retainability discount which Diamond factored into the sales of individual issues.) If that seems closer than you expected, bear in mind that with 52 superhero comics, DC were actually cutting their line back. Marvel solicited almost 80 Marvel Universe superhero books for the same month – though that may not last, given that lower selling titles are now apparently being culled.